Colitis was the most frequent adverse event on PET/CT, observed in five patients; four of these patients received PD-1 inhibitors in combination with the anti-CTLA-4 regiment ipilimumab, which is known to often induce this reaction [51, 52]. Here, CTLA4 is linked to colitis.